Generation and characterization of ABT-981, a dual variable domain immunoglobulin (DVD-Ig^TM) molecule that specifically and potently neutralizes both IL-1α and IL-1β

References

• Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity 2013; 39:1003-18; PMID:24332029; http://dx.doi.org/10.1016/j.immuni.2013.11.010
   PubMed Web of Science ®Google Scholar
• Wieland HA, Michaelis M, Kirschbaum BJ, Rudolphi KA. Osteoarthritis – an untreatable disease? Nat Rev Drug Discov 2005; 4:331-44; PMID:15803196; http://dx.doi.org/10.1038/nrd1693
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011; 117:3720-32; PMID:21304099; http://dx.doi.org/10.1182/blood-2010-07-273417
   PubMed Web of Science ®Google Scholar
• Schett G. Review: immune cells and mediators of inflammatory arthritis. Autoimmunity 2008; 41:224-9; PMID:18365836; http://dx.doi.org/10.1080/08916930701694717
   PubMed Web of Science ®Google Scholar
• Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol 2010; 10:89-102; PMID:20081871; http://dx.doi.org/10.1038/nri2691
   PubMed Web of Science ®Google Scholar
• LeGrand A, Fermor B, Fink C, Pisetsky DS, Weinberg JB, Vail TP, Guilak F. Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci. Arthritis Rheum 2001; 44:2078-83; PMID:11592370; http://dx.doi.org/10.1002/1529-0131(200109)44:9%3c2078::AID-ART358%3e3.0.CO;2-J
   PubMed Web of Science ®Google Scholar
• Barksby HE, Lea SR, Preshaw PM, Taylor JJ. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol 2007; 149:217-25; PMID:17590166; http://dx.doi.org/10.1111/j.1365-2249.2007.03441.x
   PubMed Web of Science ®Google Scholar
• O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 2008; 226:10-8; PMID:19161412; http://dx.doi.org/10.1111/j.1600-065X.2008.00701.x
   PubMed Web of Science ®Google Scholar
• Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 2007; 13:851-6; PMID:17572686; http://dx.doi.org/10.1038/nm1603
   PubMed Web of Science ®Google Scholar
• Rider P, Carmi Y, Guttman O, Braiman A, Cohen I, Voronov E, White MR, Dinarello CA, Apte RN. IL-1alpha and IL-1beta recruit different myeloid cells and promote different stages of sterile inflammation. J Immunol 2011; 187:4835-43; PMID:21930960; http://dx.doi.org/10.4049/jimmunol.1102048
   PubMed Web of Science ®Google Scholar
• Kurt-Jones EA, Fiers W, Pober JS. Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts. J Immunol 1987; 139:2317-24; PMID:3116078
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87:2095-147; PMID:8630372
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009; 27:519-50; PMID:19302047; http://dx.doi.org/10.1146/annurev.immunol.021908.132612
   PubMed Web of Science ®Google Scholar
• Kaplanski G, Farnarier C, Kaplanski S, Porat R, Shapiro L, Bongrand P, Dinarello CA. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood 1994; 84:4242-8; PMID:7994038
   PubMed Web of Science ®Google Scholar
• Niki Y, Yamada H, Seki S, Kikuchi T, Takaishi H, Toyama Y, Fujikawa K, Tada N. Macrophage- and neutrophil-dominant arthritis in human IL-1 alpha transgenic mice. J Clin Invest 2001; 107:1127-35; PMID:11342576; http://dx.doi.org/10.1172/JCI11530
   PubMed Web of Science ®Google Scholar
• Niki Y, Yamada H, Kikuchi T, Toyama Y, Matsumoto H, Fujikawa K, Tada N. Membrane-associated IL-1 contributes to chronic synovitis and cartilage destruction in human IL-1 alpha transgenic mice. J Immunol 2004; 172:577-84; PMID:14688369; http://dx.doi.org/10.4049/jimmunol.172.1.577
   PubMed Web of Science ®Google Scholar
• Scott I, Midha A, Rashid U, Ball S, Walding A, Kerry P, Delaney S, Cruwys S. Correlation of gene and mediator expression with clinical endpoints in an acute interleukin-1beta-driven model of joint pathology. Osteoarthr Cartilage 2009; 17:790-7; PMID:19010066; http://dx.doi.org/10.1016/j.joca.2008.09.016
   PubMed Web of Science ®Google Scholar
• Sachs D, Cunha FQ, Poole S, Ferreira SH. Tumour necrosis factor-alpha, interleukin-1beta and interleukin-8 induce persistent mechanical nociceptor hypersensitivity. Pain 2002; 96:89-97; PMID:11932065; http://dx.doi.org/10.1016/S0304-3959(01)00433-X
   PubMed Web of Science ®Google Scholar
• Morgan MM, Clayton CC, Heinricher MM. Dissociation of hyperalgesia from fever following intracerebroventricular administration of interleukin-1beta in the rat. Brain Res 2004; 1022:96-100; PMID:15353218; http://dx.doi.org/10.1016/j.brainres.2004.06.063
   PubMed Web of Science ®Google Scholar
• Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011; 7:33-42; PMID:21119608; http://dx.doi.org/10.1038/nrrheum.2010.196
   PubMed Web of Science ®Google Scholar
• Farahat MN, Yanni G, Poston R, Panayi GS. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1993; 52:870-5; PMID:8311538; http://dx.doi.org/10.1136/ard.52.12.870
   PubMed Web of Science ®Google Scholar
• Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 2008; 118:3537-45; PMID:18982160; http://dx.doi.org/10.1172/JCI36389
   PubMed Web of Science ®Google Scholar
• Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) 2005; 44:7-16; PMID:15292527; http://dx.doi.org/10.1093/rheumatology/keh344
   PubMed Web of Science ®Google Scholar
• Dayer JM, Graham R, Russell G, Krane SM. Collagenase production by rheumatoid synovial cells: stimulation by a human lymphocyte factor. Science 1977; 195:181-3; PMID:188134; http://dx.doi.org/10.1126/science.188134
   PubMed Web of Science ®Google Scholar
• Dayer JM, Roelke MS, Krane SM. Effects of prostaglandin E2, indomethacin, trifluoperazine and drugs affecting the cytoskeleton on collagenase production by cultured adherent rheumatoid synovial cells. Biochem Pharmacol 1984; 33:2893-9; PMID:6089839; http://dx.doi.org/10.1016/0006-2952(84)90213-2
   PubMed Web of Science ®Google Scholar
• McGuire-Goldring MB, Meats JE, Wood DD, Ihrie EJ, Ebsworth NM, Russell RG. In vitro activation of human chondrocytes and synoviocytes by a human interleukin-1-like factor. Arthritis Rheum 1984; 27:654-62; PMID:6610426; http://dx.doi.org/10.1002/art.1780270608
   PubMed Web of Science ®Google Scholar
• Goldring MB, Krane SM. Modulation by recombinant interleukin 1 of synthesis of types I and III collagens and associated procollagen mRNA levels in cultured human cells. J Biol Chem 1987; 262:16724-9; PMID:3500170
   PubMed Web of Science ®Google Scholar
• Goldring MB, Birkhead J, Sandell LJ, Kimura T, Krane SM. Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J Clin Invest 1988; 82:2026-37; PMID:3264290; http://dx.doi.org/10.1172/JCI113823
   PubMed Web of Science ®Google Scholar
• Pettipher ER, Higgs GA, Henderson B. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci U S A 1986; 83:8749-53; PMID:3490671; http://dx.doi.org/10.1073/pnas.83.22.8749
   PubMed Web of Science ®Google Scholar
• Pelletier JP, Caron JP, Evans C, Robbins PD, Georgescu HI, Jovanovic D, Fernandes JC, Martel-Pelletier J. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum 1997; 40:1012-9; PMID:9182910; http://dx.doi.org/10.1002/art.1780400604
   PubMed Web of Science ®Google Scholar
• Caron JP, Fernandes JC, Martel-Pelletier J, Tardif G, Mineau F, Geng C, Pelletier JP. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression. Arthritis Rheum 1996; 39:1535-44; PMID:8814066; http://dx.doi.org/10.1002/art.1780390914
   PubMed Web of Science ®Google Scholar
• Fernandes J, Tardif G, Martel-Pelletier J, Lascau-Coman V, Dupuis M, Moldovan F, Sheppard M, Krishnan BR, Pelletier JP. In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression. Am J Pathol 1999; 154:1159-69; PMID:10233854; http://dx.doi.org/10.1016/S0002-9440(10)65368-0
   PubMed Web of Science ®Google Scholar
• Zhang X, Yu C, Xushi, Zhang C, Tang T, Dai K. Direct chitosan-mediated gene delivery to the rabbit knee joints in vitro and in vivo. Biochem Biophys Res Commun 2006; 341:202-8; PMID:16413501; http://dx.doi.org/10.1016/j.bbrc.2005.12.171
   PubMed Web of Science ®Google Scholar
• Attur M, Belitskaya-Levy I, Oh C, Krasnokutsky S, Greenberg J, Samuels J, Smiles S, Lee S, Patel J, Al-Mussawir H, et al. Increased interleukin-1beta gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis. Arthritis Rheum 2011; 63:1908-17; PMID:21717421; http://dx.doi.org/10.1002/art.30360
   PubMed Web of Science ®Google Scholar
• Glasson SS. In vivo osteoarthritis target validation utilizing genetically-modified mice. Curr Drug Targets 2007; 8:367-76; PMID:17305514; http://dx.doi.org/10.2174/138945007779940061
   PubMed Web of Science ®Google Scholar
• Honore P, Wade CL, Zhong C, Harris RR, Wu C, Ghayur T, Iwakura Y, Decker MW, Faltynek C, Sullivan J, et al. Interleukin-1alphabeta gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain. Behav Brain Res 2006; 167:355-64; PMID:16256210; http://dx.doi.org/10.1016/j.bbr.2005.09.024
   PubMed Web of Science ®Google Scholar
• Cohen SB, Proudman S, Kivitz AJ, Burch FX, Donohue JP, Burstein D, Sun YN, Banfield C, Vincent MS, Ni L, et al. A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. Arthritis Res Ther 2011; 13:R125; PMID:21801403; http://dx.doi.org/10.1186/ar3430
   PubMed Web of Science ®Google Scholar
• Chevalier X, Giraudeau B, Conrozier T, Marliere J, Kiefer P, Goupille P. Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study. J Rheumatol 2005; 32:1317-23; PMID:15996071
   PubMed Web of Science ®Google Scholar
• Chevalier X, Goupille P, Beaulieu AD, Burch FX, Bensen WG, Conrozier T, Loeuille D, Kivitz AJ, Silver D, Appleton BE. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2009; 61:344-52; PMID:19248129; http://dx.doi.org/10.1002/art.24096
   PubMed Web of Science ®Google Scholar
• Wu C, Ying H, Bose S, Miller R, Medina L, Santora L, Ghayur T. Molecular construction and optimization of anti-human IL-1alpha/beta dual variable domain immunoglobulin (DVD-Ig) molecules. MAbs 2009; 1:339-47; PMID:20068402; http://dx.doi.org/10.4161/mabs.1.4.8755
   PubMed Web of Science ®Google Scholar
• Kamath RV, Hart M, Conlon D, Ghayur T. Simultaneous targeting of IL-1A and IL-1B by a dual-variable-domain immunoglobulin (DVD-IgTM) prevents cartilage degradation in preclinical models of osteoarthritis. Osteoarthr Cartilage 2011; S53:S64; http://dx.doi.org/10.1016/S1063-4584(11)60153-2
   Google Scholar
• Kamath RV, Simler G, Zhou C, Hart M, Joshi S, Honore P. Development and validation of mechanical allodynia as a pain readout in a preclinical model of osteoarthritis. Osteoarthr Cartilage 2012; 20:S62
   Web of Science ®Google Scholar
• Garrone P, Djossou O, Fossiez F, Banchereau J. Human monoclonal antibodies against human cytokines and methods of making and using such antibodies. Schering Corporation, 1995: Patent WO 95/14780.
   Google Scholar
• Young PR, Gross MS, Jonak ZL. Recombinant and humanized IL-1beta antibodies for treatment of IL-1 mediated inflammatory disorders in man. Smithkline Beecham Corporation, 1995: Patent WO 95/01997.
   Google Scholar
• Wu C, Ghayur T, Hsieh CM, Ambrosi DJ. IL-1 binding proteins. Abbott Laboratories, 2011: Patent US 2011/0280800.
   Google Scholar
• Dong A, Huang P, Caughey WS. Protein secondary structures in water from second-derivative amide I infrared spectra. Biochemistry 1990; 29:3303-8; PMID:2159334; http://dx.doi.org/10.1021/bi00465a022
   PubMed Web of Science ®Google Scholar
• Garber E, Demarest SJ. A broad range of Fab stabilities within a host of therapeutic IgGs. Biochem Biophys Res Commun 2007; 355:751-7; PMID:17321501; http://dx.doi.org/10.1016/j.bbrc.2007.02.042
   PubMed Web of Science ®Google Scholar
• Wu C, Ying H, Grinnell C, Bryant S, Miller R, Clabbers A, Bose S, McCarthy D, Zhu RR, Santora L, et al. Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin. Nat Biotechnol 2007; 25:1290-7; PMID:17934452; http://dx.doi.org/10.1038/nbt1345
   PubMed Web of Science ®Google Scholar
• Wines BD, Powell MS, Parren PW, Barnes N, Hogarth PM. The IgG Fc contains distinct Fc receptor (FcR) binding sites: the leukocyte receptors Fc gamma RI and Fc gamma RIIa bind to a region in the Fc distinct from that recognized by neonatal FcR and protein A. J Immunol 2000; 164:5313-8; PMID:10799893; http://dx.doi.org/10.4049/jimmunol.164.10.5313
   PubMed Web of Science ®Google Scholar
• Armour KL, van de Winkel JG, Williamson LM, Clark MR. Differential binding to human FcgammaRIIa and FcgammaRIIb receptors by human IgG wildtype and mutant antibodies. Mol Immunol 2003; 40:585-93; PMID:14597161; http://dx.doi.org/10.1016/j.molimm.2003.08.004
   PubMed Web of Science ®Google Scholar
• Rothlisberger D, Honegger A, Pluckthun A. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability. J Mol Biol 2005; 347:773-89; PMID:15769469; http://dx.doi.org/10.1016/j.jmb.2005.01.053
   PubMed Web of Science ®Google Scholar
• Wang S, Berenbaum F, Maksymowych W, Liu W, Karunaratne M, Medema JK, Abramson S. Interleukin-1 dual variable domain immunoglubulin, a new potential treatment for osteoarthritis. Osteoarthr Cartilage 2014; 22:S462-S3; http://dx.doi.org/10.1016/j.joca.2014.02.881
   Web of Science ®Google Scholar
• Wang S, Medema JK, Kosloski M, Liu W, Saltarelli MJ, Karsdal M. Interleukin-1 dual-variable domain immunoglobulin reduces multiple inflammatory markers in knee osteoarthritis patients. Ann Rheumatic Dis 2014; 73:756; PMID:23606709
   PubMed Web of Science ®Google Scholar
• Dinarello CA, Simon A, van der Meer JW. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov 2012; 11:633-52; PMID:22850787; http://dx.doi.org/10.1038/nrd3800
   PubMed Web of Science ®Google Scholar
• Benatuil L, Perez JM, Belk J, Hsieh CM. An improved yeast transformation method for the generation of very large human antibody libraries. Protein Eng Des Sel 2010; 23:155-9; PMID:20130105; http://dx.doi.org/10.1093/protein/gzq002
   PubMed Web of Science ®Google Scholar
• Feldhaus M, Siegel R. Flow Cytometric Screening of Yeast Surface Display Libraries. Totowa, NJ: Taylor & Francis.; 2004.
   Google Scholar
• Hsieh CM. Mammalian expresson vectors and uses thereof. Abbott Laboratories, 2012: Patent US 8,187,836 B2.
   Google Scholar